Register

COURSE DESCRIPTION: 
Please join us for a conference on Current and Emerging Therapies in IBD with Neilanjan Nandi, M.D., FACG, AGAF, FACP. Dr. Nandi will highlight key differences in the clinical presentation of the two major IBD phenotypes –– Crohn’s disease and ulcerative colitis –– and investigate new research into the role of hyperbaric oxygen therapy, mesenchymal stem cell therapy and microbiota restorative therapy for different forms of IBD.

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents,  Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Examine the epidemiology of inflammatory bowel disease (IBD).
• Highlight key differences in the clinical presentation of the two major IBD phenotypes –– Crohn’s disease and ulcerative colitis.
• Identify the basic mechanisms of action of different biologic and small molecule therapies in treating IBD.
• Investigate new research into the role of hyperbaric oxygen therapy, mesenchymal stem cell therapy and microbiota restorative therapy for different forms of IBD.

FACULTY AND DISCLOSURES:

Neilanjan Nandi, M.D., FACG, AGAF, FACP 
Associate Professor of Clinical Medicine 
Center for IBD
Perelman School of Medicine University of Pennsylvania
Philadelphia, Pennsylvania

Neilanjan Nandi, M.D., FACG, AGAF, FACP, faculty for this educational activity receives research support from Ferring. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.

John F. Rubin, M.D., FACP, director of this educational activity, has indicated that he is a shareholder in AstraZeneca and Bristol-Myers Squibb. All of the relevant financial relationships listed for this individual have been mitigated.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855339, by the Florida Boards of Medicine,  Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers, Laboratory Techs (Microbiology) and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.